An aged-care operator surged after reporting stronger FY26 EBITDA growth and higher embedded value.
An online retail platform rallied on double-digit sales growth and expanding profit margins across its core business.
A gold explorer gained after releasing strong drilling results ahead of a major resource upgrade.
The Australian share market witnessed strong buying momentum across healthcare, technology, and mining stocks on Tuesday, with investors reacting positively to upbeat earnings updates, improving profitability metrics, and encouraging exploration results. Companies linked to long-term structural growth themes and operational expansion attracted renewed investor interest during the session.
Among the standout performers were Oceania Healthcare Limited, Kogan.com Ltd, and Saturn Metals Limited, all of which posted sharp gains during the trading day.Stocks in Focus:
• Oceania Healthcare Limited (ASX: OCA) surged 23.1% to AU$0.64• Kogan.com Ltd (ASX: KGN) climbed 18.6% to AU$4.08• Saturn Metals Limited (ASX: STN) rose 11.2% to AU$0.595
Oceania Healthcare Jumps on Strong FY26 Performance
Oceania Healthcare Limited emerged as one of the strongest performers after the retirement village operator released its FY26 results, alongside supplementary operational updates highlighting improving profitability and asset value growth. The company reported FY26 revenue of AU$267.1 million, representing a 3% increase from the previous year, while underlying EBITDA climbed 13% to AU$97.4 million. Investors also responded positively to the company’s balance sheet strength, with net tangible assets per share increasing to AU$1.62 from AU$1.51 previously.
Market sentiment improved further after Oceania announced that its embedded value increased 2% to AU$600.1 million as at FY26. The company said the growth reflected the sell-down of available stock, onboarding of new developments at Franklin and Meadowbank, and growth in accrued deferred management fees and resale gains.
The strong rally suggested investors remain optimistic about long-term demand trends across the retirement living and aged care sector amid New Zealand’s ageing population and expanding healthcare infrastructure needs.
Kogan.com Rallies on Sales and Profit Growth
Kogan.com Ltd also recorded strong gains after the online retailer released a positive May 2026 business update highlighting improving operating leverage, expanding margins, and continued customer growth.
The company reported gross sales growth of 13.2% to AU$875.6 million during the 10 months ended 30 April 2026, while group revenue increased 6% to AU$433.7 million. Group gross profit rose 11.1% to AU$177.9 million, supported by stronger customer engagement and growth in platform-based sales.
Kogan.com’s core retail business remained the primary earnings driver, with gross sales increasing 18.2% and adjusted EBITDA jumping 32% compared to the prior corresponding period. The company also noted that group adjusted EBITDA margin reached 8.6%, positioning results near the upper end of FY26 guidance.
Investors also welcomed signs of improving performance at Mighty Ape, where adjusted EBITDA losses narrowed significantly during the January-April 2026 period as management continued to implement cost reductions and higher-margin strategies.
Saturn Metals Gains on High-Grade Gold Drilling Results
Saturn Metals Limited advanced after the gold explorer released encouraging drilling results from its Apollo Hill Gold Project in Western Australia, reinforcing expectations for a future Mineral Resource upgrade. The company reported several notable high-grade gold intersections, including 16 metres at 2.46g/t gold from 47 metres and 22 metres at 1.58g/t gold from 26 metres. Management stated that the latest drilling continues to strengthen the case for improvements to the current 2.24-million-ounce Apollo Hill Mineral Resource.
Saturn Metals also confirmed that an updated Mineral Resource estimate is expected to be released in the coming weeks and will underpin the project’s Definitive Feasibility Study and updated Ore Reserve planned later in 2026. The company’s Apollo Hill project currently hosts a Mineral Resource of 137.1Mt at 0.51g/t gold for 2.239 million ounces, positioning it as one of the larger undeveloped gold projects in Western Australia. Investor optimism surrounding future resource growth and development potential helped drive strong buying activity in the stock.
The gains across healthcare, technology, and gold exploration stocks highlighted continued investor appetite for companies delivering operational growth, improving profitability, and long-term expansion opportunities despite broader market volatility.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Why Are These 3 ASX Stocks Suddenly in Focus?
Highlights:
The Australian share market witnessed strong buying momentum across healthcare, technology, and mining stocks on Tuesday, with investors reacting positively to upbeat earnings updates, improving profitability metrics, and encouraging exploration results. Companies linked to long-term structural growth themes and operational expansion attracted renewed investor interest during the session.
Among the standout performers were Oceania Healthcare Limited, Kogan.com Ltd, and Saturn Metals Limited, all of which posted sharp gains during the trading day.Stocks in Focus:
• Oceania Healthcare Limited (ASX: OCA) surged 23.1% to AU$0.64• Kogan.com Ltd (ASX: KGN) climbed 18.6% to AU$4.08• Saturn Metals Limited (ASX: STN) rose 11.2% to AU$0.595
Oceania Healthcare Jumps on Strong FY26 Performance
Oceania Healthcare Limited emerged as one of the strongest performers after the retirement village operator released its FY26 results, alongside supplementary operational updates highlighting improving profitability and asset value growth. The company reported FY26 revenue of AU$267.1 million, representing a 3% increase from the previous year, while underlying EBITDA climbed 13% to AU$97.4 million. Investors also responded positively to the company’s balance sheet strength, with net tangible assets per share increasing to AU$1.62 from AU$1.51 previously.
Market sentiment improved further after Oceania announced that its embedded value increased 2% to AU$600.1 million as at FY26. The company said the growth reflected the sell-down of available stock, onboarding of new developments at Franklin and Meadowbank, and growth in accrued deferred management fees and resale gains.
The strong rally suggested investors remain optimistic about long-term demand trends across the retirement living and aged care sector amid New Zealand’s ageing population and expanding healthcare infrastructure needs.
Kogan.com Rallies on Sales and Profit Growth
Kogan.com Ltd also recorded strong gains after the online retailer released a positive May 2026 business update highlighting improving operating leverage, expanding margins, and continued customer growth.
The company reported gross sales growth of 13.2% to AU$875.6 million during the 10 months ended 30 April 2026, while group revenue increased 6% to AU$433.7 million. Group gross profit rose 11.1% to AU$177.9 million, supported by stronger customer engagement and growth in platform-based sales.
Kogan.com’s core retail business remained the primary earnings driver, with gross sales increasing 18.2% and adjusted EBITDA jumping 32% compared to the prior corresponding period. The company also noted that group adjusted EBITDA margin reached 8.6%, positioning results near the upper end of FY26 guidance.
Investors also welcomed signs of improving performance at Mighty Ape, where adjusted EBITDA losses narrowed significantly during the January-April 2026 period as management continued to implement cost reductions and higher-margin strategies.
Saturn Metals Gains on High-Grade Gold Drilling Results
Saturn Metals Limited advanced after the gold explorer released encouraging drilling results from its Apollo Hill Gold Project in Western Australia, reinforcing expectations for a future Mineral Resource upgrade. The company reported several notable high-grade gold intersections, including 16 metres at 2.46g/t gold from 47 metres and 22 metres at 1.58g/t gold from 26 metres. Management stated that the latest drilling continues to strengthen the case for improvements to the current 2.24-million-ounce Apollo Hill Mineral Resource.
Saturn Metals also confirmed that an updated Mineral Resource estimate is expected to be released in the coming weeks and will underpin the project’s Definitive Feasibility Study and updated Ore Reserve planned later in 2026. The company’s Apollo Hill project currently hosts a Mineral Resource of 137.1Mt at 0.51g/t gold for 2.239 million ounces, positioning it as one of the larger undeveloped gold projects in Western Australia. Investor optimism surrounding future resource growth and development potential helped drive strong buying activity in the stock.
The gains across healthcare, technology, and gold exploration stocks highlighted continued investor appetite for companies delivering operational growth, improving profitability, and long-term expansion opportunities despite broader market volatility.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au